Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry

Ying Ren Wang, Shin Fu Chen, Chyuan Chuan Wu, Yi Wen Liao, Te Sheng Lin, Ko Ting Liu, Yi Song Chen, Tsai Kun Li, Tun Cheng Chien, Nei Li Chan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Human type II topoisomerase (Top2) isoforms, hTop2α and hTop2β, are targeted by some of the most successful anticancer drugs. These drugs induce Top2-mediated DNA cleavage to trigger cell-death pathways. The potency of these drugs correlates positively with their efficacy in stabilizing the enzyme-mediated DNA breaks. Structural analysis of hTop2α and hTop2β revealed the presence of methionine residues in the drugbinding pocket, we therefore tested whether a tighter Top2-drug association may be accomplished by introducing a methionine-reactive Pt2+ into a drug to further stabilize the DNA break. Herein, we synthesized an organoplatinum compound, etoplatin-N2β, by replacing the methioninejuxtaposing group of the drug etoposide with a cis-dichlorodiammineplatinum(II) moiety. Compared to etoposide, etoplatin-N2β more potently inhibits both human Top2s. While the DNA breaks arrested by etoposide can be rejoined, those captured by etoplatin-N2β are practically irreversible. Crystallographic analyses of hTop2β complexed with DNA and etoplatin-N2β demonstrate coordinate bond formation between Pt2+ and a flanking methionine. Notably, this stable coordinate tether can be loosened by disrupting the structural integrity of drug-binding pocket, suggesting that Pt2+ coordination chemistry may allow for the development of potent inhibitors with protein conformation-dependent reversibility. This approach may be exploited to achieve isoformspecific targeting of human Top2s.

Original languageEnglish
Pages (from-to)10861-10871
Number of pages11
JournalNucleic Acids Research
Volume45
Issue number18
DOIs
Publication statusPublished - 2017 Oct 13

Fingerprint

Type II DNA Topoisomerase
DNA Breaks
Methionine
Pharmaceutical Preparations
Etoposide
Organoplatinum Compounds
DNA Cleavage
Protein Conformation
Cisplatin
Protein Isoforms
Cell Death
DNA
Enzymes

ASJC Scopus subject areas

  • Genetics

Cite this

Wang, Y. R., Chen, S. F., Wu, C. C., Liao, Y. W., Lin, T. S., Liu, K. T., ... Chan, N. L. (2017). Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry. Nucleic Acids Research, 45(18), 10861-10871. https://doi.org/10.1093/nar/gkx742

Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry. / Wang, Ying Ren; Chen, Shin Fu; Wu, Chyuan Chuan; Liao, Yi Wen; Lin, Te Sheng; Liu, Ko Ting; Chen, Yi Song; Li, Tsai Kun; Chien, Tun Cheng; Chan, Nei Li.

In: Nucleic Acids Research, Vol. 45, No. 18, 13.10.2017, p. 10861-10871.

Research output: Contribution to journalArticle

Wang, YR, Chen, SF, Wu, CC, Liao, YW, Lin, TS, Liu, KT, Chen, YS, Li, TK, Chien, TC & Chan, NL 2017, 'Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry', Nucleic Acids Research, vol. 45, no. 18, pp. 10861-10871. https://doi.org/10.1093/nar/gkx742
Wang, Ying Ren ; Chen, Shin Fu ; Wu, Chyuan Chuan ; Liao, Yi Wen ; Lin, Te Sheng ; Liu, Ko Ting ; Chen, Yi Song ; Li, Tsai Kun ; Chien, Tun Cheng ; Chan, Nei Li. / Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry. In: Nucleic Acids Research. 2017 ; Vol. 45, No. 18. pp. 10861-10871.
@article{002ce6ae214746359e42bf6b05a41cff,
title = "Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry",
abstract = "Human type II topoisomerase (Top2) isoforms, hTop2α and hTop2β, are targeted by some of the most successful anticancer drugs. These drugs induce Top2-mediated DNA cleavage to trigger cell-death pathways. The potency of these drugs correlates positively with their efficacy in stabilizing the enzyme-mediated DNA breaks. Structural analysis of hTop2α and hTop2β revealed the presence of methionine residues in the drugbinding pocket, we therefore tested whether a tighter Top2-drug association may be accomplished by introducing a methionine-reactive Pt2+ into a drug to further stabilize the DNA break. Herein, we synthesized an organoplatinum compound, etoplatin-N2β, by replacing the methioninejuxtaposing group of the drug etoposide with a cis-dichlorodiammineplatinum(II) moiety. Compared to etoposide, etoplatin-N2β more potently inhibits both human Top2s. While the DNA breaks arrested by etoposide can be rejoined, those captured by etoplatin-N2β are practically irreversible. Crystallographic analyses of hTop2β complexed with DNA and etoplatin-N2β demonstrate coordinate bond formation between Pt2+ and a flanking methionine. Notably, this stable coordinate tether can be loosened by disrupting the structural integrity of drug-binding pocket, suggesting that Pt2+ coordination chemistry may allow for the development of potent inhibitors with protein conformation-dependent reversibility. This approach may be exploited to achieve isoformspecific targeting of human Top2s.",
author = "Wang, {Ying Ren} and Chen, {Shin Fu} and Wu, {Chyuan Chuan} and Liao, {Yi Wen} and Lin, {Te Sheng} and Liu, {Ko Ting} and Chen, {Yi Song} and Li, {Tsai Kun} and Chien, {Tun Cheng} and Chan, {Nei Li}",
year = "2017",
month = "10",
day = "13",
doi = "10.1093/nar/gkx742",
language = "English",
volume = "45",
pages = "10861--10871",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry

AU - Wang, Ying Ren

AU - Chen, Shin Fu

AU - Wu, Chyuan Chuan

AU - Liao, Yi Wen

AU - Lin, Te Sheng

AU - Liu, Ko Ting

AU - Chen, Yi Song

AU - Li, Tsai Kun

AU - Chien, Tun Cheng

AU - Chan, Nei Li

PY - 2017/10/13

Y1 - 2017/10/13

N2 - Human type II topoisomerase (Top2) isoforms, hTop2α and hTop2β, are targeted by some of the most successful anticancer drugs. These drugs induce Top2-mediated DNA cleavage to trigger cell-death pathways. The potency of these drugs correlates positively with their efficacy in stabilizing the enzyme-mediated DNA breaks. Structural analysis of hTop2α and hTop2β revealed the presence of methionine residues in the drugbinding pocket, we therefore tested whether a tighter Top2-drug association may be accomplished by introducing a methionine-reactive Pt2+ into a drug to further stabilize the DNA break. Herein, we synthesized an organoplatinum compound, etoplatin-N2β, by replacing the methioninejuxtaposing group of the drug etoposide with a cis-dichlorodiammineplatinum(II) moiety. Compared to etoposide, etoplatin-N2β more potently inhibits both human Top2s. While the DNA breaks arrested by etoposide can be rejoined, those captured by etoplatin-N2β are practically irreversible. Crystallographic analyses of hTop2β complexed with DNA and etoplatin-N2β demonstrate coordinate bond formation between Pt2+ and a flanking methionine. Notably, this stable coordinate tether can be loosened by disrupting the structural integrity of drug-binding pocket, suggesting that Pt2+ coordination chemistry may allow for the development of potent inhibitors with protein conformation-dependent reversibility. This approach may be exploited to achieve isoformspecific targeting of human Top2s.

AB - Human type II topoisomerase (Top2) isoforms, hTop2α and hTop2β, are targeted by some of the most successful anticancer drugs. These drugs induce Top2-mediated DNA cleavage to trigger cell-death pathways. The potency of these drugs correlates positively with their efficacy in stabilizing the enzyme-mediated DNA breaks. Structural analysis of hTop2α and hTop2β revealed the presence of methionine residues in the drugbinding pocket, we therefore tested whether a tighter Top2-drug association may be accomplished by introducing a methionine-reactive Pt2+ into a drug to further stabilize the DNA break. Herein, we synthesized an organoplatinum compound, etoplatin-N2β, by replacing the methioninejuxtaposing group of the drug etoposide with a cis-dichlorodiammineplatinum(II) moiety. Compared to etoposide, etoplatin-N2β more potently inhibits both human Top2s. While the DNA breaks arrested by etoposide can be rejoined, those captured by etoplatin-N2β are practically irreversible. Crystallographic analyses of hTop2β complexed with DNA and etoplatin-N2β demonstrate coordinate bond formation between Pt2+ and a flanking methionine. Notably, this stable coordinate tether can be loosened by disrupting the structural integrity of drug-binding pocket, suggesting that Pt2+ coordination chemistry may allow for the development of potent inhibitors with protein conformation-dependent reversibility. This approach may be exploited to achieve isoformspecific targeting of human Top2s.

UR - http://www.scopus.com/inward/record.url?scp=85032983616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032983616&partnerID=8YFLogxK

U2 - 10.1093/nar/gkx742

DO - 10.1093/nar/gkx742

M3 - Article

C2 - 28977631

AN - SCOPUS:85032983616

VL - 45

SP - 10861

EP - 10871

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 18

ER -